Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization

Area of Science:

• Molecular biology
• Cancer research
• Biophysics

Background:

• Epidermal growth factor receptor (EGFR) mutations and overexpression are linked to various cancers.
• EGFR is a dimerization-activated receptor tyrosine kinase and a key target for cancer therapeutics.

Purpose of the Study:

• To investigate the structural dynamics of the wild-type and mutated EGFR kinase domain.
• To elucidate the molecular mechanisms by which cancer-associated mutations, such as L834R, affect EGFR dimerization and activity.

Main Methods:

• Long-timescale molecular dynamics simulations of EGFR kinase domain.
• Biophysical experiments.
• Kinase enzymatic assays.

Main Results:

• The N lobe dimerization interface of wild-type EGFR kinase domain is intrinsically disordered, becoming ordered upon dimerization.
• Cancer-linked mutations, notably L834R, promote EGFR dimerization by reducing this intrinsic disorder.
• The L834R mutation increases EGFR activity primarily through enhanced dimerization, not activation independent of dimerization.
• Phosphorylation at Tyr845 may suppress intrinsic disorder, suggesting a mechanism for autonomous EGFR signaling.

Conclusions:

• EGFR dimerization is a critical step regulated by the intrinsic disorder of its kinase domain.
• Specific mutations like L834R confer oncogenic potential by stabilizing the dimeric state of EGFR.
• Targeting EGFR dimerization represents a viable strategy for cancer therapy.